🎉 Founding Member Beta — Join our Discord and get 3 months of Pro free. Learn more →

Integra LifeSciences Holdings Corporation

IART Healthcare
$9.53 $-0.04 (-0.42%)
Market Cap: $742.74 M
Gurus Holding
4
Popularity Rank
#2155
% of Shares Held
0.40%
Net Activity (Q4 2025)
-$3.26 M

Guru Ownership Trend

Guru Analysis for Integra LifeSciences Holdings Corporation (IART)

Integra LifeSciences Holdings Corporation (IART), a key player in the Healthcare sector, continues to attract institutional attention.

As of Q4 2025, a total of 4 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $2.96 M.

Top institutional holders include Robert Olstein and Cliff Asness.

Institutional sentiment is currently Slightly Bearish. This is evidenced by a $3.26 M net outflow during the quarter.

Recent activity highlights Renaissance Technologies (RenTech) who opened a new position. Conversely, Robert Olstein reduced exposure by 11.5%.

Key Holders

Recent Activity Breakdown (Q4 2025)

+$183,319
Total Buy Value
New Buys 1
Additions 0
-$3.45 M
Total Sell Value
Reductions 3
Sold Out 2

Guru Consensus (Q4 2025)

Based on recent activity
Net Sellers
5
Net Buyers
1

FAQs for Integra LifeSciences Holdings Corporation (IART)

Major holders include Robert Olstein ($1.53 M), Cliff Asness ($1.48 M), Louis Moore Bacon ($662,359). According to the latest reported data, 4 tracked investment managers collectively hold approximately 310,561 shares.

According to the latest 13F reporting period, sentiment appears Bearish (Net Selling). There was a net outflow of $3.26 M, with 1 managers increasing positions and 5 managers reducing holdings.

During the most recent reporting period, 3 managers trimmed their positions, while 2 fully exited IART. The total reported sell value was $3.45 M.

Yes, 1 managers opened new positions in IART, and 0 increased their existing holdings. The total reported buy value was $183,319.

Portfolio Manager % Portfolio Activity Shares Value Report Date
0.31% Reduce -11.5% 123,000 $1.53 M Q4 2025
0.00% Reduce -8.5% 119,471 $1.48 M Q4 2025
0.01% Reduce -3.5% 53,330 $662,359 Q4 2025
0.00% New Buy 14,760 $183,319 Q4 2025
Date
Insider Name
Transaction
Value
Shares
Position / Chg
SEC Form